UBS Group
AFIB

UBS Group’s Acutus Medical Inc AFIB Stock Holding History

UBS Group’s Portfolio AFIB Stock Details AFIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-301
Closed -$57 – 10395
2024
Q1 		$57 Sell
301
-6,524
-96% -$1.29K ﹤0.01% 8913
2023
Q4 		$1.38K Buy
+6,825
New +$2.67K ﹤0.01% 8320
2023
Q2 		– Sell
-7,166
Closed -$5.4K – 9984
2023
Q1 		$5.4K Sell
7,166
-5,386
-43% -$7.02K ﹤0.01% 8042
2022
Q4 		$14.4K Buy
12,552
+3,379
+37% +$2.79K ﹤0.01% 8074
2022
Q3 		$8K Buy
9,173
+5,607
+157% +$6.79K ﹤0.01% 8774
2022
Q2 		$4K Buy
3,566
+3,284
+1,165% +$2.82K ﹤0.01% 9179
2022
Q1 		$0 Sell
282
-5,248
-95% -$11.2K ﹤0.01% 11134
2021
Q4 		$18K Buy
+5,530
New +$31.1K ﹤0.01% 8005
2021
Q3 		– Sell
-47,660
Closed -$810K – 10270
2021
Q2 		$810K Buy
47,660
+3,401
+8% +$49.8K ﹤0.01% 4360
2021
Q1 		$592K Buy
44,259
+16,323
+58% +$367K ﹤0.01% 4745
2020
Q4 		$805K Buy
27,936
+27,024
+2,963% +$731K ﹤0.01% 4193
2020
Q3 		$27K Buy
+912
New +$27.7K ﹤0.01% 6083

Other funds holding AFIB

SAM
S.A. Mason Holland, Michigan $266M AUM 26.42% 1-Year Est. Return

UBS Group's AFIB Position: Q2 2024 in Review

UBS Group sold out of Acutus Medical Inc (AFIB) in Q2 2024, closing a stake of 301 shares — an estimated $57 sold.

UBS Group first reported a position in AFIB in Q3 2020 and held it in 12 quarters. The position peaked at $810K in Q2 2021. 1 fund tracked by Wall St. Rank holds AFIB as of Q2 2024.

  • UBS Group reported no remaining Acutus Medical Inc position as of Q2 2024 after selling out during the quarter.
  • UBS Group sold 301 Acutus Medical Inc shares in Q2 2024, an estimated $57.
  • UBS Group first reported a position in Acutus Medical Inc in Q3 2020 and held it in 12 quarters.
  • UBS Group's Acutus Medical Inc position peaked at $810K in Q2 2021.
  • 1 fund tracked by Wall St. Rank held Acutus Medical Inc as of Q2 2024.

Based on UBS Group's 13F filing for Q2 2024, filed 14 Aug 2024.